92 related articles for article (PubMed ID: 3293350)
1. Circulating class II transplantation antigen-expressing T lymphocytes in children with insulin-dependent diabetes mellitus at diagnosis.
Karlsson-Parra A; Kobbah M; Ewald U; Tuvemo T; Forsum U; Klareskog L
Acta Paediatr Scand; 1988 Jul; 77(4):554-8. PubMed ID: 3293350
[TBL] [Abstract][Full Text] [Related]
2. Abnormal lymphocyte subsets in Kuwaiti patients with type-1 insulin-dependent diabetes mellitus and their first-degree relatives.
Kaaba SA; Al-Harbi SA
Immunol Lett; 1995 Sep; 47(3):209-13. PubMed ID: 8747721
[TBL] [Abstract][Full Text] [Related]
3. HLA typing data on 100 type 1 (insulin-dependent) diabetic patients from central Italy show a negative association with DR5 rather than with DR2.
Vela M; Adorno D; Longo A; Papola F; Maccarone D; Centis D; Raponi MP; Candela A; Campea L; Orsini M
Clin Immunol Immunopathol; 1987 Oct; 45(1):143-6. PubMed ID: 3497749
[TBL] [Abstract][Full Text] [Related]
4. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
[TBL] [Abstract][Full Text] [Related]
5. Association of HLA-DQw3 (TA10-) with type I diabetes occurs with DR3/4 but not DR1/4 patients.
Tait BD; Mraz G; Harrison LC
Diabetes; 1988 Jul; 37(7):926-9. PubMed ID: 3260201
[TBL] [Abstract][Full Text] [Related]
6. Increased CD69 and human leukocyte antigen-DR expression on T lymphocytes in insulin-dependent diabetes mellitus of long standing.
Gessl A; Waldhäusl W
J Clin Endocrinol Metab; 1998 Jun; 83(6):2204-9. PubMed ID: 9626161
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
Ferber KM; Keller E; Albert ED; Ziegler AG
J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR binding analysis of peptides from islet antigens in IDDM.
Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO
Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297
[TBL] [Abstract][Full Text] [Related]
9. Genomic HLA-DQ beta polymorphism associated with insulin-dependent diabetes mellitus. Analysis of possible functional significance.
Bruserud O; Paulsen G; Markussen G; Lundin K; Thoresen AB; Thorsby E
Scand J Immunol; 1987 Mar; 25(3):235-43. PubMed ID: 2951844
[TBL] [Abstract][Full Text] [Related]
10. Analysis of families at risk for insulin-dependent diabetes mellitus reveals that HLA antigens influence progression to clinical disease.
Honeyman MC; Harrison LC; Drummond B; Colman PG; Tait BD
Mol Med; 1995 Jul; 1(5):576-82. PubMed ID: 8529124
[TBL] [Abstract][Full Text] [Related]
11. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
[TBL] [Abstract][Full Text] [Related]
12. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children.
Sugihara S; Sakamaki T; Konda S; Murata A; Wataki K; Kobayashi Y; Minamitani K; Miyamoto S; Sasaki N; Niimi H
Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042
[TBL] [Abstract][Full Text] [Related]
14. Lymphocyte subset abnormalities, autoantibodies and their relationship with HLA DR types in children with type 1 (insulin-dependent) diabetes and their first degree relatives.
Peakman M; Warnock T; Vats A; McNab GL; Underhill J; Donaldson PT; Vergani D
Diabetologia; 1994 Feb; 37(2):155-65. PubMed ID: 8163049
[TBL] [Abstract][Full Text] [Related]
15. The antibody response to insulin therapy. A prospective study in HLA-typed insulin-dependent diabetic subjects.
Asplin CM; Dornan TL; Raghu PK; Hansen JA; Palmer JP
Diabetes; 1984 Oct; 33(10):966-9. PubMed ID: 6383905
[TBL] [Abstract][Full Text] [Related]
16. HLA antigens of insulin-dependent diabetics. I. PLT colonies detecting Dw10 and a new class II determinant distinct from HLA-D, DR, MB(DC), MT, and SB.
Sheehy MJ; Quintieri FB; Yang SY; Alosco SM; Matsui Y; Yunis EJ; Gabbay KH
Tissue Antigens; 1984 May; 23(5):290-300. PubMed ID: 6205468
[TBL] [Abstract][Full Text] [Related]
17. HLA-DR4 in insulin-dependent diabetic parents and their diabetic offspring: a clue to dominant inheritance.
MacDonald MJ; Gottschall J; Hunter JB; Winter KL
Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7049-53. PubMed ID: 3489237
[TBL] [Abstract][Full Text] [Related]
18. The majority of the activated T cells in the blood of insulin-dependent diabetes mellitus (IDDM) patients are CD4+.
De Berardinis P; Londei M; Kahan M; Balsano F; Kontiainen S; Gale EA; Bottazzo GF; Feldmann M
Clin Exp Immunol; 1988 Aug; 73(2):255-9. PubMed ID: 2972427
[TBL] [Abstract][Full Text] [Related]
19. Class I HLA is associated with age-at-onset of IDDM, while class II HLA confers susceptibility to IDDM.
Fujisawa T; Ikegami H; Kawaguchi Y; Yamato E; Takekawa K; Nakagawa Y; Hamada Y; Ueda H; Shima K; Ogihara T
Diabetologia; 1995 Dec; 38(12):1493-5. PubMed ID: 8786033
[No Abstract] [Full Text] [Related]
20. HLA heterogeneity of insulin-dependent diabetes mellitus at diagnosis. The Pittsburgh IDDM study.
Eberhardt MS; Wagener DK; Orchard TJ; LaPorte RE; Cavender DE; Rabin BS; Atchison RW; Kuller LH; Drash AL; Becker DJ
Diabetes; 1985 Dec; 34(12):1247-52. PubMed ID: 2998911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
